Table 4 

Proportion of the phenotypic variance explained by the markers significantly associated with the evaluated traits 

Trait^{1} 
Family 
LG 
Method^{2 }and QTL position (cM) 
Marker^{3} 
Marker position (cM)^{4} 
R^{2 }(%) 


Re 
FamAS2 
4 
LR: 0/ML: 10 
SmaUSC47 
0.00 
7.4 
FamAS3 
6 
LR: 0/ML: 26 
SmaUSC147 
4.52 
16.2 

FamAP 
5 
ML: 21 
SmaUSCE30 
0.00 
8.9 

9 
LR: 31/ML: 38 
SmaUSCE23 
30.75 
10.5 

SmaUSCE41 
45.68 
12.4 

SmaUSC21 
53.91 
11.6 

16 
ML: 35 
SmaUSC256 
32.75 
13.6 

Su 
FamAS2 
4 
LR: 0/ML: 10 
SmaUSC47 
0.00 
8.1 
11 
LR: 43 
SmaUSC158 
23.39 
10.1 

FamAS3 
6 
LR: 0/ML: 26 
SmaUSC147 
4.52 
16.8 

FamAP 
5 
ML: 19 
SmaUSCE30 
0.00 
8.9 

9 
LR: 31/ML: 36 
SmaUSCE23 
30.75 
12.3 

SmaUSCE41 
45.68 
12.8 

SmaUSC21 
53.91 
12.0 

16 
ML: 36 
SmaUSC256 
32.75 
12.4 



^{1}Re: resistance; Su: survival. LG: linkage group. ^{2}LR: linear regression method; ML: maximum likelihood method; ^{3}BLAST annotation [17] was only recorded for SmaUSC23 (3Hydroxibutirate dehydrogenase type 2) and SmaUSC41 (Helicase with zinc finger domain). ^{4}Marker position in centimorgan (cM) within the genetic map by Bouza et al. [17]. R^{2 }(%): proportion of the explained phenotypic variance. 

RodrÃguezRamilo et al. BMC Genomics 2011 12:541 doi:10.1186/1471216412541 